Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

146 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Harnessing Real-World Evidence to Advance Cancer Research.
Tang M, Pearson SA, Simes RJ, Chua BH. Tang M, et al. Among authors: chua bh. Curr Oncol. 2023 Feb 2;30(2):1844-1859. doi: 10.3390/curroncol30020143. Curr Oncol. 2023. PMID: 36826104 Free PMC article. Review.
ESTRO ACROP consensus guideline for target volume delineation in the setting of postmastectomy radiation therapy after implant-based immediate reconstruction for early stage breast cancer.
Kaidar-Person O, Vrou Offersen B, Hol S, Arenas M, Aristei C, Bourgier C, Cardoso MJ, Chua B, Coles CE, Engberg Damsgaard T, Gabrys D, Jagsi R, Jimenez R, Kirby AM, Kirkove C, Kirova Y, Kouloulias V, Marinko T, Meattini I, Mjaaland I, Nader Marta G, Witt Nystrom P, Senkus E, Skyttä T, Tvedskov TF, Verhoeven K, Poortmans P. Kaidar-Person O, et al. Radiother Oncol. 2019 Aug;137:159-166. doi: 10.1016/j.radonc.2019.04.010. Epub 2019 May 17. Radiother Oncol. 2019. PMID: 31108277
Postmastectomy radiotherapy: a review.
Kunkler IH, Chua BH. Kunkler IH, et al. Among authors: chua bh. Curr Opin Oncol. 2021 Nov 1;33(6):547-552. doi: 10.1097/CCO.0000000000000789. Curr Opin Oncol. 2021. PMID: 34494609 Review.
Dataset for pathology reporting of ductal carcinoma in situ, variants of lobular carcinoma in situ and low-grade lesions: recommendations from the International Collaboration on Cancer Reporting (ICCR).
Fox SB, Webster F, Chen CJ, Chua B, Collins L, Foschini MP, Bruce Mann G, Millar E, Pinder SE, Rakha E, Shaaban A, Tan BY, Tse G, Watson P, Tan PH. Fox SB, et al. Histopathology. 2022 Oct;81(4):467-476. doi: 10.1111/his.14725. Epub 2022 Aug 8. Histopathology. 2022. PMID: 35869801 Review.
Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3-07/TROG 07.01): a randomised, factorial, multicentre, open-label, phase 3 study.
Chua BH, Link EK, Kunkler IH, Whelan TJ, Westenberg AH, Gruber G, Bryant G, Ahern V, Purohit K, Graham PH, Akra M, McArdle O, O'Brien P, Harvey JA, Kirkove C, Maduro JH, Campbell ID, Delaney GP, Martin JD, Vu TTT, Muanza TM, Neal A, Olivotto IA; BIG 3–07/TROG 07.01 trial investigators. Chua BH, et al. Lancet. 2022 Aug 6;400(10350):431-440. doi: 10.1016/S0140-6736(22)01246-6. Lancet. 2022. PMID: 35934006 Clinical Trial.
146 results